Home Spexis

Spexis

In operation
Post-IPO Round
Biopharmaceutical Manufacturer

Basic Information

Spexis is a clinical-stage biopharmaceutical company headquartered in Switzerland, focusing on rare diseases and oncology. Its mission is to discover and develop innovative drugs to help patients in need of novel transformative treatments.
Spexis, Ltd.
CantonofBasel-City,Switzerland
15~50 people
January 01, 1996
info@spexisbio.com